 |
 |
 |
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
|
 |
|
|
Ilan is a Partner of Prospect Venture
Partners. Prior to joining Prospect Venture Partners III, Ilan
was a Principal at MPM Capital, and had been promoted to General
Partner for MPM's next fund. At MPM, Ilan was involved with
investments in biotechnology and specialty pharmaceutical
companies including Somaxon Pharmaceuticals (NASDAQ:SOMX),
Neuromed Pharmaceuticals, Pharmasset, KaloBios, Rinat
Neuroscience and ARYx Therapeutics. Ilan also worked with MPM
Capital's BioEquities hedge fund, which invests in small- to
mid-cap public biotechnology companies. Prior to joining MPM
Capital in 2000, Ilan was the Science Editor of BioCentury
Publications Inc., a biotechnology news and analysis
publication. Ilan received a Ph.D. in cell biology and
biochemistry from the University of California at San Francisco
(UCSF), and a B.A. in Molecular and Cell Biology from U.C.
Berkeley. |
 |